Latest filing published 16 Mar 2026 for Surgery Partners, Inc., €40k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Marissa Brittenham (senior executive) discloses dealings in Surgery Partners, Inc. to SEC (Form 4). In total, 12 filings cover trades dated from 1 February 2022 to 13 March 2026.
The open-market record consists of 7 sales worth €703k, with no purchase. Other entries cover 5 share grants. Since January 2026: no purchases and 2 sales on the market.
On 16 March 2026 came the latest disclosure, an open-market sale for €40k in Surgery Partners, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations